Matt Cobler-Lichter

Degree: Bachelor of Arts in Neuroscience from College of the Holy Cross in 2019. MD candidate at Jacobs School of Medicine and Biomedical Sciences at University at Buffalo (2021-2025)

Position: Research Assistant in Neurovascular Research Unit

Department / Institution: Neurology/Massachusetts General Hospital

Supported by: David Chung

Research: Clinical subarachnoid hemorrhage


Peer-Reviewed Journal Articles
Atallah NJ, Warren HM, Roberts MB, Elshaboury RH, Bidell MR, Gandhi RG, Adamsick M, Ibrahim MK,
Sood R, Bou Zein Eddine S, Cobler-Lichter MJ, Alexander NJ, Timmer KD, Atallah CJ, Viens AL,
Panossian VS, Scherer AK, Proctor T, Smartt S, Letourneau AR, Paras ML, Johannes S, Wiemer J, Mansour
MK. (2022). Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19:
A case-control study. PLoS One 17(1): e0262342.

Poster Presentations
Cobler-Lichter MJ, Daneshmand A, Tatro H, Cascone A, Yang J, Greer D, Cervantes-Arslanian A,
Takahashi C, Ong C, Abdalkader MK, Dasenbrock HH, Nguyen T, Chung D, Suchdev K. Association of
valproic acid use and discharge outcomes after aneurysmal subarachnoid hemorrhage. 2021. Neurocritical
Care Society, Chicago, IL.

• Email: